Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HSBC analyst Wesley Brooks upgraded Copart, Inc. (NASDAQ:CPRT) from Hold to Buy and raised the price target from $56 to $62. Copart shares closed at $48.12 on Wednesday. See how other analysts view this stock.
- RBC Capital analyst Ken Herbert upgraded Leidos Holdings, Inc. (NYSE:LDOS) from Sector Perform to Outperform and raised the price target from $180 to $210. Leidos shares closed at $177.64 on Wednesday. See how other analysts view this stock.
- Evercore ISI Group analyst David Palmer upgraded the rating for Brinker International, Inc. (NYSE:EAT) from In-Line to Outperform and raised the price target from $190 to $210. Brinker International shares closed at $159.12 on Wednesday. See how other analysts view this stock.
- Maxim Group analyst Jason McCarthy upgraded Coherus Oncology, Inc. (NASDAQ:CHRS) from Hold to Buy and announced a $4 price target. Coherus Oncology shares closed at $1.18 on Wednesday. See how other analysts view this stock.
- Maxim Group analyst Caroline Palomeque upgraded Daré Bioscience, Inc. (NASDAQ:DARE) from Hold to Buy and announced a price target of $8. Dare Bioscience shares closed at $2.06 on Wednesday. See how other analysts view this stock.
Considering buying EAT stock? Here’s what analysts think:
Photo via Shutterstock
